Philip Morris International Inc. reported a better-than-expected profit for the fourth quarter of 2024, with revenue reaching $9.71 billion, surpassing Wall Street's estimates of $9.44 billion, marking a 7.3% increase year-over-year. The company's adjusted earnings per share (EPS) stood at $1.55, beating the consensus estimate of $1.50 by 3.4%. The growth was driven by strong demand for its Zyn nicotine pouches, with U.S. shipments reaching nearly 165 million cans, marking a 42% increase year-over-year, and a 46% overall year-over-year growth for Zyn. Outside the U.S., Zyn's quarterly shipment volume more than doubled. Additionally, the company's reduced-risk products, including IQOS and Zyn, now account for nearly 40% of its total revenue. Philip Morris shares rose significantly in premarket trading, up by as much as 10% following the earnings announcement. The company's adjusted operating income was $3.2 billion, and its operating margin improved to 33.6% from 31.9% in the same quarter last year. Sales volumes were up 2.3% year-over-year. The company's CEO, Jacek Olczak, highlighted the strong performance of IQOS and Zyn, along with a robust combustibles performance, as key drivers of the company's success in 2024. Philip Morris also provided a positive outlook for the first quarter of 2025, expecting net revenue and operating income growth in line with full-year objectives, with a forecast of around 10% growth in Heated Tobacco Units (HTU) adjusted IMS.